You are here

Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Toyota-shi, Aichi, 471-8513 Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Community-Acquired Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Hospitalized Japanese descent subjects known or suspected to have CAP with a severity
that requires IV antibiotic treatment.

- Chest radiograph within 48 hours before the first dose of IV test article showing the
presence of a new infiltrate.

- The presence of fever or hypothermia within 24 hours before the first administration
of test article, and of at least two signs/symptoms of CAP within 24 hours before the
first administration of test article.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any concomitant condition that, in the opinion of the investigator, would preclude an
evaluation of a response or make it unlikely that the contemplated course of therapy
could be completed.

- Hospital-acquired pneumonia, other lung disease including viral, fungal, or parasitic
pneumonia, immunosuppressive conditions, and other illness, which affect evaluation of
safety and efficacy of tigecycline.

- Known or suspected hypersensitivity to tigecycline or tetracyclines, or
contraindication for these antibiotics.

NCT00575094
Pfizer
Completed
Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Community-Acquired Infections
NCT00575094
All Genders
20+
Years
Multiple Sites
Community-Acquired Infections, Bacterial Pneumonia, Cross Infection
NCT00081575
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now